PARRY, ROMANI, DECONCINI & SYMMS for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
Monitor legislation regulating agreements between pharmaceutical companies to settle patent infringement lawsuits.
Foreign entity interest: sanofi-aventis U.S. Inc. is owned 100% by sanofi-aventis SA (France) and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too sanofi-aventis SA, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| DENNIS DECONCINI | — |
| JAMES ROCK | — |
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Copyright/Patent/Trademark CPT
Oppose importation of unsafe drugs from outside the United States. Monitor S. 515, Patent Law Reform. Support amendments to strengthen patent enforcement.
Foreign entity interest: sanofi-aventis U.S. Inc. is owned 100% by sanofi-aventis SA (France) and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too sanofi-aventis SA, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| DENNIS DECONCINI | — |
| JAMES ROCK | — |
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Financial Institutions/Investments/Securities FIN
Monitor legislation reforming the Committee on Foreign Investment in the United States process.
Foreign entity interest: sanofi-aventis U.S. Inc. is owned 100% by sanofi-aventis SA (France) and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too sanofi-aventis SA, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| DENNIS DECONCINI | — |
| JAMES ROCK | — |
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Medical/Disease Research/Clinical Labs MED
Monitor Affordable Biologics for Consumers Act and Biologics Price Competition and Innovation Act of 2007, support enactment and follow-on Biologics legislation with amendments that strengthen FDA pathway and provide data exclusivity. H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007.
Foreign entity interest: sanofi-aventis U.S. Inc. is owned 100% by sanofi-aventis SA (France) and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so too sanofi-aventis SA, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| EDWARD H BAXTER | — |
| DENNIS DECONCINI | — |
| JAMES ROCK | — |
| ROMANO ROMANI | — |
| THADDEUS E STROM | — |
| STEVE SYMMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.